NervGen Pharma's total assets for Q3 2025 were C$13.08M, a decrease of -22.73% from the previous quarter. TSE:NGEN total liabilities were C$16.02M for the fiscal quarter, a -10.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.